Search for Clinical Trial Results

Sponsored By

Eosinophilic Esophagitis - 7 Studies Found

Status Study
NOT_YET_RECRUITING Study Name: Validation in French of a Quality of Life Questionnaire for Patients With Eosinophilic Esophagitis in Pediatrics
Condition:
Date: 2024-10-13
Interventions: Measurement of the quality of life of patients with eosinophilic esophagitis by the PedsQL questionnaire eosinophilic esophagitis module
RECRUITING Study Name: A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Date: 2024-10-13
Interventions: Oral solution
RECRUITING Study Name: Zemaira Eosinophilic Esophagitis Pilot Study
Condition: Eosinophilic Esophagitis
Date: 2024-10-13
Interventions: Intravenous infusion at 120 mg/kg body weight dose/week for 12 weeks for a total of 12 infusions.
RECRUITING Study Name: Imaging of the Esophagus Using a SECM Capsule
Condition: Eosinophilic Esophagitis
Date: 2024-10-13
Interventions: Subjects will swallow a SECM capsule and the SECM imaging will be performed
RECRUITING Study Name: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Date: 2024-10-13
Interventions: subcutaneous administration
COMPLETED Study Name: Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Date: 2024-10-13
Interventions: 1-hour intravenous infusion
COMPLETED Study Name: 24-Week Induction Study of APT-1011 in Adult Subjects with Eosinophilic Esophagitis (EoE) (FLUTE 3)
Condition: Eosinophilic Esophagitis
Date: 2024-10-13
Interventions: APT-1011 is an orally disintegrating tablet that includes fluticasone propionate as its active ingredient.Other Names:fluticasone pro